ESMO: European Society for Medical Oncology

  1. Doxolipad, a hybrid medicine, contains the active substance doxorubicin
  2. The next research and innovation framework programme
  3. PURE findings reflect transition in the predominant causes of deaths in middle-age
  4. The review was triggered by data from several studies showing a higher number of skin cancer cases in patients using a gel for treating actinic keratosis
  5. Third international consensus meeting-based guidelines